4.8 Article

Tumor delivery of Photofrin® by PLL-g-PEG for photodynamic therapy

期刊

JOURNAL OF CONTROLLED RELEASE
卷 167, 期 3, 页码 315-321

出版社

ELSEVIER
DOI: 10.1016/j.jconrel.2013.02.016

关键词

Photodynamic therapy; Graft copolymer; Non-covalent complex; EPR effect

资金

  1. Japan Society for the Promotion of Science (JSPS) [20500410, 24510300, 23240074]
  2. Ministry of Education, Culture, Science, Sports and Technology of Japan (MEXT) [2306]
  3. Grants-in-Aid for Scientific Research [20500410, 24510300, 23240074] Funding Source: KAKEN

向作者/读者索取更多资源

Photofrin (R) (porfimer sodium) is a photosensitive reagent used for photodynamic therapy (PDT) of tumors and dysplasias. Because only photo-irradiated sites are damaged, PDT is less invasive than systemic treatments. However, a photosensitive reaction is a major side effect of systemically delivered Photofrin. To enhance localization of Photofrin to tumors, we have formulated Photofrin with the tumor-localizing graft copolymer poly(ethylene glycol)-grafted poly(L-lysine), PLL-g-PEG. We demonstrate that Photofrin preferentially interacts with PLL-g-PEG through both ionic and hydrophobic interactions. The serum competitive study showed that the highly PEG-grafted PLL is better for preventing serum binding to the Photofrin/PLL-g-PEG complex. In tumor-bearing mice, formulation of Photofrin with PLL-g-PEG enhanced tumor localization of Photofrin as twice as Photofrin alone and concomitantly suppressed the photosensitivity reaction drastically. (C) 2013 Elsevier B. V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据